When did Johnson & Johnson buy and sell its brands?

Johnson & Johnson has completed 0 recorded acquisitions and 1 divestiture or spin-off, spanning 2023 to 2023.

Date	Type	Assets	Counterparty	Value
Aug 2023	Spin-off	Tylenol, Band-Aid, Listerine and Neutrogena +9	Kenvue	—

2023

Spin-off closed Closed 23 August 2023

Tylenol, Band-Aid, Listerine, Neutrogena, Aveeno, Johnson's Baby, Nicorette, Zyrtec, Motrin, Benadryl, OGX, Carefree and Stayfree separated from Johnson & Johnson

Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.

Value: —
Buyer: Kenvue
Seller: Johnson & Johnson
Regulatory: None recorded

Brands Johnson & Johnson once owned

Ownership recorded here as having ended, whether or not a deal record with a filing behind it exists for the transfer.

Brand	Owned from	Until	Owner today
Johnson's Baby	Jan 1893	Aug 2023	Kenvue
Band-Aid	Jan 1920	Aug 2023	Kenvue
Tylenol	Jan 1959	Aug 2023	Kenvue
Stayfree	Jan 1970	Aug 2023	Kenvue
Carefree	Jan 1974	Aug 2023	Kenvue
Neutrogena	Jan 1994	Aug 2023	Kenvue
Aveeno	Jan 1999	Aug 2023	Kenvue
Listerine	Dec 2006	Aug 2023	Kenvue
Nicorette	Dec 2006	Aug 2023	Kenvue
Zyrtec	Dec 2006	Aug 2023	Kenvue
Motrin	Dec 2006	Aug 2023	Kenvue
Benadryl	Dec 2006	Aug 2023	Kenvue
OGX	Sep 2016	Aug 2023	Kenvue